Emcure Pharmaceuticals Ltd (EMCURE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Emcure Pharmaceuticals Ltd (EMCURE) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.56 Billion ≈ $27.71 Million USD) by net assets (Rs48.84 Billion ≈ $528.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EMCURE days of operational coverage to measure how many days the company can operate on defensive assets alone.

Emcure Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2022–2026)

This chart illustrates how Emcure Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Emcure Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Emcure Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chongqing Brewery Co Ltd SHG:600132	0.242x
Uni-President China Holdings Ltd F:58U	0.031x
nLIGHT Inc NASDAQ:LASR	0.077x
China Coal Xinji Energy Co Ltd SHG:601918	0.053x
X Trade Brokers Dom Maklerski SA WAR:XTB	0.096x
CIE Automotive S.A. MC:CIE	0.329x
Laboratorios Farmaceuticos ROVI MC:ROVI	0.116x
Suzhou Zelgen Biopharmaceuticals Co Ltd SHG:688266	0.000x

Annual Cash Flow Conversion Efficiency for Emcure Pharmaceuticals Ltd (2022–2026)

The table below shows the annual cash flow conversion efficiency of Emcure Pharmaceuticals Ltd from 2022 to 2026. For the full company profile with market capitalisation and key ratios, see market cap of Emcure Pharmaceuticals Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs49.77 Billion ≈ $538.21 Million	Rs8.51 Billion ≈ $91.98 Million	0.171x	-6.86%
2025-03-31	Rs46.42 Billion ≈ $501.97 Million	Rs8.52 Billion ≈ $92.11 Million	0.183x	-47.79%
2024-03-31	Rs31.22 Billion ≈ $337.61 Million	Rs10.97 Billion ≈ $118.66 Million	0.351x	+24.70%
2023-03-31	Rs26.50 Billion ≈ $286.55 Million	Rs7.47 Billion ≈ $80.77 Million	0.282x	-22.43%
2022-03-31	Rs21.14 Billion ≈ $228.64 Million	Rs7.68 Billion ≈ $83.08 Million	0.363x	--

About Emcure Pharmaceuticals Ltd

NSE:EMCURE India Drug Manufacturers - Specialty & Generic

Market Cap

$3.50 Billion

Rs323.36 Billion INR

Market Cap Rank

#4575 Global

#192 in India

Share Price

Rs1705.60

Change (1 day)

-1.76%

52-Week Range

Rs1243.10 - Rs1793.20

All Time High

Rs1793.20